Tuesday, October 29, 2024
Innovative Research

UTSA announces partnership with Bristol Myers Squibb to advance pharmaceutical discoveries and development

UTSA announces partnership with Bristol Myers Squibb to advance pharmaceutical discoveries and development

Students in the Frantz Laboratory (from left to right) are undergraduate chemistry majors William Palmer and Meredith Slimp and Ph.D. chemistry students Nicolas Wilson and Cody Phillips.

OCTOBER 28, 2024 — UTSA was selected for a new grant that will foster a partnership with Bristol Myers Squibb (BMS), an industry leader in pharmaceutical development. The partnership will assist BMS with its work to discover new chemical reactions that will aid in the development of novel pharmaceutical manufacturing routes that are more efficient and better for the environment.

UTSA was awarded $615,000 in funding from the National Science Foundation (NSF) through its prestigious Grant Opportunities for Academic Liaison with Industry (GOALI) program. The award will fund the research through 2027.

The NSF created GOALI to provide supplemental funding that fosters collaborations between academic institutions and industry partners to accelerate new discoveries that would be challenging for either partner to achieve independently. GOALI awards undergo a rigorous review process and are highly competitive. This is the second GOALI award for UTSA.


“The broader impacts this funding will have on my students Department of Chemistry and the team at BMS cannot be overstated.”


Doug Frantz, the Max and Minnie Tomerlin Voelcker Endowed Chair of Chemistry and principal investigator on the project, will partner with BMS, one of the world’s largest pharmaceutical companies, on the award. Frantz has worked alongside BMS to publish several peer-reviewed articles over the past six years. One of their most recent publications went on to become one of last year’s most read articles in Organometallics, a leading journal in the field of organometallic chemistry.

“The highly successful collaboration my research group already has with BMS was the perfect opportunity to submit a GOALI proposal to the NSF to further catalyze our future success,” said Frantz.

The goal of this project is to discover and develop new catalysts that can control chemical reactivity in a class of compounds that are highly relevant to the pharmaceutical industry. BMS will utilize their high-throughput experimentation (HTE) capabilities that enable scientists to conduct thousands of reactions per week to identify new catalysts that can be refined in the Frantz Laboratory.

“BMS is excited to extend our partnership with Professor Frantz and his research group. The GOALI program will enable continuation and expansion of an already successful collaboration with a number of positive benefits for both the organizations and students involved in the research,” said Michael Hobbs, vice president of chemical process development.

Additionally, the program will provide a unique training environment for UTSA students in Frantz’s research group. They will have the opportunity to work directly with BMS scientists and gain professional career experience with a leading pharmaceutical firm.

“I am extremely grateful for this opportunity that Doug Frantz has provided for me to be a part of the collaboration with one of the biggest and well-known companies in the pharmaceutical industry,” said Nicolas Wilson, a graduate student on the Ph.D. track in chemistry who hopes to one day work in the pharmaceutical industry. “I am in constant communication with some of the brightest minds in industry which has, without a doubt, further deepened my knowledge and understanding of chemistry.”

Meredith Slimp, a UTSA junior majoring in chemistry, believes working on a project of this caliber is a dream opportunity for an undergraduate.

“Working with the Frantz group at UTSA, as well as the amazing team at Bristol Myers Squibb, is something that will leave me with profound experience and knowledge that will help me through graduate school, as well as my following career,” she added.


EXPLORE FURTHER
Learn more about Frantz’ research collaborations, including with CPRIT.
⇒ Read more information about the impact of the Max and Minnie Tomerlin Voelcker Fund.
⇒ Read about Jayce Rhodes '18, '21, a UTSA chemistry graduate who became a senior associate scientist at Bristol Myers Squibb. 

 

Frantz started his professional career in the pharmaceutical industry working as a process chemist to develop new and efficient chemical syntheses for small molecule drug candidates. This background provided him with an in-depth understanding of the issues process chemists face in the pharmaceutical industry and has allowed him to leverage his academic and industrial experience to assist with these challenges.

“The broader impacts this funding from the NSF will have on my students, the UTSA Department of Chemistry and the team of outstanding scientists at BMS cannot be overstated,” said Frantz. “This award from the NSF will support our ongoing and highly successful collaboration with BMS and catalyze new discoveries at the forefront of synthetic organic chemistry while also providing a unique experiential training program for undergraduate and graduate students here at UTSA.”

Ryan Schoensee



UTSA Today is produced by University Strategic Communications,
the official news source
of The University of Texas at San Antonio.

Send your feedback to news@utsa.edu.


UTSA Today is produced by University Communications and Marketing, the official news source of The University of Texas at San Antonio. Send your feedback to news@utsa.edu. Keep up-to-date on UTSA news by visiting UTSA Today. Connect with UTSA online at Facebook, Twitter, Youtube and Instagram.


Events


Spotlight

Spotlight

spotlight-utsa-uthsa3.png
UTSA & UT Health San Antonio integration

UTSA’s Mission

The University of Texas at San Antonio is dedicated to the advancement of knowledge through research and discovery, teaching and learning, community engagement and public service. As an institution of access and excellence, UTSA embraces multicultural traditions and serves as a center for intellectual and creative resources as well as a catalyst for socioeconomic development and the commercialization of intellectual property - for Texas, the nation and the world.

UTSA’s Vision

To be a premier public research university, providing access to educational excellence and preparing citizen leaders for the global environment.

UTSA’s Core Values

We encourage an environment of dialogue and discovery, where integrity, excellence, inclusiveness, respect, collaboration and innovation are fostered.

UTSA’S Destinations

UTSA is a proud Hispanic Serving Institution (HSI) as designated by the U.S. Department of Education .

Our Commitment to Inclusivity

The University of Texas at San Antonio, a Hispanic Serving Institution situated in a global city that has been a crossroads of peoples and cultures for centuries, values diversity and inclusion in all aspects of university life. As an institution expressly founded to advance the education of Mexican Americans and other underserved communities, our university is committed to promoting access for all. UTSA, a premier public research university, fosters academic excellence through a community of dialogue, discovery and innovation that embraces the uniqueness of each voice.